New pill aims to stop weight loss drug side effects
NCT ID NCT07446439
Summary
This study is testing if a drug called tradipitant can reduce the nausea and vomiting that some people experience when taking GLP-1 weight loss medications. It will involve 280 overweight or obese adults who do not have diabetes. Participants will be randomly assigned to receive either tradipitant or a placebo (inactive pill) to see which one better controls these side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vanda Investigational Site
Los Angeles, California, 90025, United States
Contact Phone: •••-•••-••••
-
Vanda Investigational Site
New York, New York, 10016, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.